Login / Signup

Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation.

Omer H JamyRaquel Innis-SheltonSusan BalRavi PaluriDonna SalzmanAntonio Di StasiLuciano José Megale CostaRuby MeredithLawrence LambKentaro MinagawaShin MineishiAyman Saad
Published in: American journal of hematology (2021)
Keyphrases